Excessive neutrophilic
inflammation contributes to brain pathology and adverse outcome in
pneumococcal meningitis (PM). Recently, we identified the NLRP3
inflammasome/
interleukin (IL)-1β pathway as a key driver of
inflammation in PM. A critical membrane receptor for NLRP3
inflammasome activation is the
ATP-activated
P2 purinoceptor (P2R) P2X7. Thus, we hypothesized involvement of
ATP and P2Rs in PM. The functional role of
ATP was investigated in a mouse
meningitis model using P2R antagonists. Brain expression of P2Rs was assessed by RT-PCR.
ATP levels were determined in murine CSF and cell culture experiments. Treatment with the P2R antagonists
suramin or
brilliant blue G did not have any impact on disease course. This lack of effect might be attributed to
meningitis-associated down-regulation of brain P2R expression and/or a drop of cerebrospinal fluid (CSF)
ATP, as demonstrated by RT-PCR and
ATP analyses. Supplemental cell culture experiments suggest that the reduction in CSF
ATP is, at least partly, due to
ATP hydrolysis by ectonucleotidases of neutrophils and macrophages. In conclusion, this study suggests that ATP-P2R signaling is only of minor or even no significance in PM. This may be explained by down-regulation of P2R expression and decreased CSF
ATP levels.